Osaka, Japan

Naohiro Onodera

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Toyonaka, JP (2014)
  • Osaka, JP (2010 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Naohiro Onodera: Innovator in Pharmaceutical Chemistry

Introduction

Naohiro Onodera is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors related to allergic diseases. With a total of four patents to his name, Onodera's work is recognized for its potential therapeutic applications.

Latest Patents

Onodera's latest patents include a sulfonamide derivative that exhibits PGD2 receptor antagonistic activity. This invention provides a pharmaceutical composition that includes the sulfonamide derivative as an active ingredient, aimed at treating allergic diseases. The compound is described by a general formula, showcasing its innovative approach to addressing health issues related to allergies.

Career Highlights

Throughout his career, Naohiro Onodera has been associated with Shionogi & Company Limited, a well-respected pharmaceutical company. His work has focused on creating effective therapeutic agents that can improve the quality of life for individuals suffering from allergic conditions. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Onodera has collaborated with notable colleagues, including Akira Kugimiya and Masahiko Fujioka. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking pharmaceutical solutions.

Conclusion

Naohiro Onodera's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in treating allergic diseases, showcasing the importance of research and collaboration in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…